<DOC>
	<DOC>NCT00161655</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy to clear or almost clear the plaques in plaque psoriasis patients, treated with the combination etanercept and methotrexate compared to etanercept alone.</brief_summary>
	<brief_title>Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Arthritis, Psoriatic</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Active plaque psoriasis involving &gt;10% body surface area and/or minimal screening PASI score 8. Methotrexate &gt;7.5 mg/week for the last 3 months Predominantly guttate, erythrodermic or pustular psoriasis Other skin conditions than psoriasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Arthritis</keyword>
</DOC>